{"nctId":"NCT00283816","briefTitle":"Impact of Metformin in Teens With Polycystic Ovary Syndrome (PCOS) on Oral Contraceptive Therapy","startDateStruct":{"date":"2006-01"},"conditions":["Polycystic Ovary Syndrome"],"count":36,"armGroups":[{"label":"1","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Metformin","Drug: Oral Contraceptive Pill","Behavioral: Lifestyle Management Program","Behavioral: Quality of Life Questionnaire","Procedure: Oral Glucose Tolerance Test","Procedure: Blood work","Procedure: Abdominal Ultra Sound","Procedure: Dual-energy x-ray absorptiometry (DEXA scan)"]},{"label":"0","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Oral Contraceptive Pill","Behavioral: Lifestyle Management Program","Behavioral: Quality of Life Questionnaire","Procedure: Oral Glucose Tolerance Test","Procedure: Blood work","Procedure: Abdominal Ultra Sound","Procedure: Dual-energy x-ray absorptiometry (DEXA scan)","Drug: placebo"]}],"interventions":[{"name":"Metformin","otherNames":["Metformin Hydrochloride Tablets, 500 mg.","manufacturer: Mylan Pharmaceuticals, Morgantown, WV"]},{"name":"Oral Contraceptive Pill","otherNames":["Yasmin 28 tablets","Manufacturer: Berlex, Montville, NJ 07045"]},{"name":"Lifestyle Management Program","otherNames":[]},{"name":"Quality of Life Questionnaire","otherNames":[]},{"name":"Oral Glucose Tolerance Test","otherNames":[]},{"name":"Blood work","otherNames":[]},{"name":"Abdominal Ultra Sound","otherNames":[]},{"name":"Dual-energy x-ray absorptiometry (DEXA scan)","otherNames":[]},{"name":"placebo","otherNames":["placebo formulation: 240 mg. lactose powder USP","in size 3 capsules from Capsugel"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:Age 12-18 years; Menstrual irregularity; Overweight; Must be able to swallow capsules; At lease 6 months since onset of first menstrual cycle.\n\nExclusion Criteria:Diabetes; Kidney or Liver disease; Tobacco use; Depression or Bipolar Disease; Contraindication to exercise; Weight \\> 300 lbs.","healthyVolunteers":true,"sex":"FEMALE","minimumAge":"12 Years","maximumAge":"18 Years","stdAges":["CHILD","ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Reduction in Abdominal Fat as Measured by Waist Circumference.","description":"Change in waist circumference measured in cms used as a measure of abdominal adiposity, pre minus post intervention","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.9","spread":"8.6"},{"groupId":"OG001","value":"-1.4","spread":"10.9"}]}]}]},{"type":"SECONDARY","title":"Change in Weight Post Minus Pre Intervention.","description":"Body mass index change in adolescents enrolled in lifestyle intervention program","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.9","spread":"4.7"},{"groupId":"OG001","value":"-1.2","spread":"4.5"}]}]}]},{"type":"SECONDARY","title":"Total Testosterone Change","description":"Change in total testosterone post minus pre intervention","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-57.7","spread":"21.7"},{"groupId":"OG001","value":"-27.6","spread":"30.1"}]}]}]},{"type":"SECONDARY","title":"Change in Sex Hormone Binding Globulin (SHBG)","description":"SHBG concentration post minus pre-intervention","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-73.4","spread":"31.9"},{"groupId":"OG001","value":"-58","spread":"34.3"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":18},"commonTop":[]}}}